Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, is the exclusive provider of the Lyme Borreliosis Nanotrap® Urine Test.
This first-of-its-kind Lyme Antigen test provides the most sensitive direct detection of Borrelia burgdorferi infection at all stages of the disease. The test provides advantages blood serum testing does not, namely:
Identifies positive cases missed by CDC-recommended Two-Tiered Testing (TTT)
Reduces concern for false positive results via direct detection of OspA proteins
Easy to collect urine samples
The revolutionary test greatly increases the likelihood of Lyme detection via innovative Nanotrap® technology developed by CERES Nanosciences. Nanotrap® particles capture and concentrate low abundance Outer Surface Protein A (OspA) in urine samples, followed by confirmation using a highly sensitive Western blot.